Neuro - Do you think it likely that Cortex's competitors don't already know most (if not all) of the details of Cortex's histo problem with CX-717? I guess Cortex has to continue with the assumption that the FDA hold detail info is still secure, but it seems likely to me that it isn't. And if the competitors know the info, likely the big money investors know it as well. Which means that only small investors don't have the info. Just thinking out loud, I know the additional details are not going to be provided in a CC... Aiming4.